It has been successfully used in morphea (open-label examine), prurigo nodularis (randomized double-blind trial), lichen amy- Resiquimod loidosis (double-blind pilot research), lichen sclerosis-et- atrophicans, recalcitrant Grover’s illness, confluent and re- It is a stronger and soluble analogue ...